David Y. Mitchell, Ph.D. has been appointed vice president and executive consultant at ClinPharm Consulting, LLC. Dr. Mitchell has 20 years of experience guiding projects at Array BioPharma, OSI Pharmaceuticals, and Pfizer, and has directed clinical pharmacology programs at Pfizer and Procter & Gamble Pharmaceuticals in the areas of oncology, neuroscience, and bone disease. He currently serves as president of the American Association of Pharmaceutical Scientists (AAPS). He has published more than 60 manuscripts, chapters, and abstracts in the areas of pharmacokinetics, metabolism, toxicology, and epidemiology.
 
“Dr. Mitchell is an accomplished pharmacokinetic and drug development consultant and we are very pleased to have him bring his professional and scientific talents to ClinPharm,” said Geoffrey Banks, Ph.D., ClinPharm president and chief executive officer. “As ClinPharm’s vice president and executive consultant of clinical pharmacology and PK, Dr. Mitchell will enable clients to conduct more effective human clinical trials by taking complex pharmacokinetic principals and making them understandable and usable for common sense drug development.”